Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2Thoracic 1Genitourinary 1

Conditions

Lung Neoplasms 39Carcinoma, Non-Small-Cell Lung 28Breast Neoplasms 7Prostatic Neoplasms 6Small Cell Lung Carcinoma 5Pancreatic Neoplasms 4Head and Neck Neoplasms 4Colonic Neoplasms 4Triple Negative Breast Neoplasms 3Rectal Neoplasms 3Ovarian Neoplasms 3Esophageal Neoplasms 3Colorectal Neoplasms 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Pulmonary Disease, Chronic Obstructive 2Neoplasms 2Uterine Neoplasms 1Urogenital Neoplasms 1Tobacco Use 1Smoking 1Skin Neoplasms 1Signs and Symptoms 1Sarcoma 1Recurrence 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Motor Activity 1Melanoma 1

Interventions

Carboplatin 25Pemetrexed 19Cisplatin 18pembrolizumab 14Paclitaxel 14Gemcitabine 8osimertinib 7durvalumab 6Docetaxel 6Nivolumab 5Erlotinib Hydrochloride 5130-nm albumin-bound paclitaxel 5capmatinib 3brigatinib 3anlotinib 3Gefitinib 3Drug Therapy 3vosaroxin 2volociximab 2sintilimab 2pralsetinib 2ensartinib 2atezolizumab 2aflibercept 2Surgical Procedures, Operative 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Radiation 2Oncolytic Virotherapy 2Midazolam 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma × Standard of Care × Thoracic × Clear all
NCT07135882 2025-08-22

PRIME-Lung

Trans Tasman Radiation Oncology Group

Phase 3 Not yet recruiting
420 enrolled
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡